Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Pollastri

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|December 20, 2018
Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug DevelopmentKelly A Bachovchin, Amrita Sharma, Seema Bag, et al.
Molecular Pharmacology|August 28, 2014
In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivoAshley J Parks, Michael P Pollastri, Mark E Hahn, et al.
Journal of Medicinal Chemistry|November 1, 2019
Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis TherapeuticsDana M Klug, Laura Tschiegg, Rosario Diaz, et al.
Journal of Medicinal Chemistry|October 26, 2011
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sicknessNicholas D Bland, Cuihua Wang, Craig Tallman, et al.
Plos Neglected Tropical Diseases|October 24, 2014
Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaignRosario Diaz, Sandra A Luengo-Arratta, João D Seixas, et al.
Plos Neglected Tropical Diseases|February 9, 2019
Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agentsDana M Klug, Rosario Diaz-Gonzalez, Guiomar Pérez-Moreno, et al.
Journal of Medicinal Chemistry|December 18, 2019
Selectivity and Physicochemical Optimization of Repurposed Pyrazolo[1,5-<i>b</i>]pyridazines for the Treatment of Human African TrypanosomiasisWestley F Tear, Seema Bag, Rosario Diaz-Gonzalez, et al.
ACS Infectious Diseases|July 7, 2023
Structure-Property Optimization of a Series of Imidazopyridines for Visceral LeishmaniasisMaria Dichiara, Quillon J Simpson, Antonio Quotadamo, et al.
Journal of Medicinal Chemistry|August 13, 2024
Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of <i>Trypanosoma brucei</i>Lori Ferrins, Rosario Diaz, Carlos Cordon-Obras, et al.
Journal of Medicinal Chemistry|September 20, 2025
Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1<i>H</i>-Pyrrolo[2,3<i>b</i>]pyridines Inhibitors of Trypanosome ProliferationKelly A Bachovchin, Rosario Díaz, Gloria Ceballos-Perez, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|December 20, 2018
Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug DevelopmentKelly A Bachovchin, Amrita Sharma, Seema Bag, et al.
Molecular Pharmacology|August 28, 2014
In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivoAshley J Parks, Michael P Pollastri, Mark E Hahn, et al.
Journal of Medicinal Chemistry|November 1, 2019
Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis TherapeuticsDana M Klug, Laura Tschiegg, Rosario Diaz, et al.
Journal of Medicinal Chemistry|October 26, 2011
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sicknessNicholas D Bland, Cuihua Wang, Craig Tallman, et al.
Plos Neglected Tropical Diseases|October 24, 2014
Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaignRosario Diaz, Sandra A Luengo-Arratta, João D Seixas, et al.
Plos Neglected Tropical Diseases|February 9, 2019
Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agentsDana M Klug, Rosario Diaz-Gonzalez, Guiomar Pérez-Moreno, et al.
Journal of Medicinal Chemistry|December 18, 2019
Selectivity and Physicochemical Optimization of Repurposed Pyrazolo[1,5-<i>b</i>]pyridazines for the Treatment of Human African TrypanosomiasisWestley F Tear, Seema Bag, Rosario Diaz-Gonzalez, et al.
ACS Infectious Diseases|July 7, 2023
Structure-Property Optimization of a Series of Imidazopyridines for Visceral LeishmaniasisMaria Dichiara, Quillon J Simpson, Antonio Quotadamo, et al.
Journal of Medicinal Chemistry|August 13, 2024
Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of <i>Trypanosoma brucei</i>Lori Ferrins, Rosario Diaz, Carlos Cordon-Obras, et al.
Journal of Medicinal Chemistry|September 20, 2025
Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1<i>H</i>-Pyrrolo[2,3<i>b</i>]pyridines Inhibitors of Trypanosome ProliferationKelly A Bachovchin, Rosario Díaz, Gloria Ceballos-Perez, et al.
Pageof 7